Leadstar Media Unveils New Brand Identity in BookmakerBonus.it Website Renewal 31-03-2025, 22:40

Founder Group Limited Secures US$2.36 million Contract for a 30MW Large Scale Solar Plant in Malaysia 10-09-2025, 19:30

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26